Mealey's (August 16, 2017, 12:05 PM EDT) -- PHOENIX — Insys Therapeutics Inc. on Aug. 3 announced that it has taken a $4.5 million charge for a potential settlement of Illinois’ consumer fraud lawsuit over the drug company’s alleged off-label promotion of the fentanyl-based opioid Subsys....